Q1 2019

Source filing unavailable

Q1 2019 · —

Revenue—

Net Income

-$5.83M

N/M vs Q1 2018

EPS Diluted

-$3.24

N/M vs Q1 2018

Operating Income-$5,916,000—

Operating Cash Flow-$6,150,000—

Free Cash Flowderived-$6,609,000—

Same quarter

Metric	Q1 2019	Q1 2018
Net Income	-$5.83M	-$4.15M
EPS Diluted	-$3.24	-$3.03

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Korro Bio, Inc. · CIK 1703647 · Engraved from SEC EDGAR